AstraZeneca, the United Kingdom’s most valuable publicly listed company, has secured the backing of leading shareholder advisory groups for its proposal to achieve a direct listing on the New York
All posts tagged in New York Stock Exchange
5Articles
The Prime Minister recently convened with Sir Pascal Soriot, the chief executive of AstraZeneca, at Downing Street to discuss the government’s efforts to bolster UK capital markets. This meeting came
AstraZeneca, one of Britain’s leading pharmaceutical giants, has announced its intention to secure a direct listing on the New York Stock Exchange in a strategic move aimed at strengthening its
The competition for initial public offerings (IPOs) between London and New York has intensified, with both financial centres employing various strategies to attract British companies. Recent discussions have highlighted the
In a move that could further dampen the appeal of the London Stock Exchange, TP ICAP, the City’s top inter-dealer broker, has revealed that it is considering listing its data
